Camila Linardi

发表

Cost effectiveness of positron emission tomography in patients with Hodgkin's lymphoma in unconfirmed complete remission or partial remission after first-line therapy.

J. C. Meneghetti, D. Delbeke, F. Pitella, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

18F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin Lymphoma

J. S. Júnior, J. C. Meneghetti, D. Delbeke, 2010, The Journal of Nuclear Medicine.

Reassessment of risk factors and long‐term results of autologous stem cell transplantation in relapsed and refractory classical Hodgkin lymphoma

V. Rocha, Camila Linardi, V. Buccheri, 2019, Hematological oncology.

Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions.

S. Fanti, J. C. Meneghetti, P. Zinzani, 2011, Clinical lymphoma, myeloma & leukemia.

Thalidomide treatment down-regulates SDF-1alpha and CXCR4 expression in multiple myeloma patients.

M. Metzger, D. Maria, S. Bydlowski, 2009, Leukemia research.

Direct comparison of two extended half-life PEGylated recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A

A. Iorio, M. Mancuso, T. Lissitchkov, 2020, Annals of Hematology.

Mice with targeted disruption of the Dio2 gene have cold-induced overexpression of the uncoupling protein 1 gene but fail to increase brown adipose tissue lipogenesis and adaptive thermogenesis.

A. Bianco, E. Kimura, M. Christoffolete, 2004, Diabetes.

Treatment of Hodgkin's lymphoma after failure of autologous stem cell transplant

L. F. Pracchia, Camila Linardi, V. Buccheri, 2008 .

Safety and efficacy of BAY 94-9027, an extended-half-life factor VIII, during surgery in patients with severe hemophilia A: Results of the PROTECT VIII clinical trial.

E. Santagostino, H. Ng, S. Lalezari, 2019, Thrombosis research.

Safety and efficacy of BAY 94–9027, an extended‐half‐life factor VIII, during minor surgical procedures in patients with severe haemophilia A

E. Santagostino, H. Ng, S. Lalezari, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Diagnosis and treatment of polycythemia vera: Brazilian experience from a single institution

L. F. Pracchia, Camila Linardi, V. Buccheri, 2008, Sao Paulo medical journal = Revista paulista de medicina.

Dealing with bone marrow biopsies in the staging of classical Hodgkin lymphoma: an old issue revisited in the 18F-fluorodeoxyglucose-positron emission tomography era

H. M. de Paula, M. Zerbini, J. Cerci, 2015, Leukemia & lymphoma.

Differential expression of HOXB7 gene in multiple myeloma and extramedullary multiple myeloma patients

M. Metzger, D. Maria, S. Bydlowski, 2010, European journal of haematology.

Evaluation of survival risk scores in primary myelofibrosis: A Brazilian experience from a single institution

L. F. Pracchia, Camila Linardi, V. Buccheri, 2008, Leukemia & lymphoma.

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma

Camila Linardi, V. Buccheri, D. Chamone, 2011, Revista brasileira de hematologia e hemoterapia.

An Individual Patient Supply Program for Ruxolitinib for the Treatment of Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

G. Barosi, C. Harrison, H. Gisslinger, 2012 .

Evaluation of chromosomal abnormalities by clg-FISH and association with proliferative and apoptotic indexes in multiple myeloma

Camila Linardi, V. Buccheri, E. Velloso, 2012, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

First-in-Human Dose-Finding Study of AAVhu37 Vector-Based Gene Therapy: BAY 2599023 Has Stable and Sustained Expression of FVIII over 2 Years

S. Pipe, T. Lissitchkov, H. Eichler, 2021, Blood.